Insomnia disorder increases the risk of subjective memory decline in middle-aged and older adults: a longitudinal analysis of the Canadian Longitudinal Study on Aging.


Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
09 11 2022
Historique:
received: 24 03 2022
revised: 13 07 2022
pubmed: 26 7 2022
medline: 11 11 2022
entrez: 25 7 2022
Statut: ppublish

Résumé

To examine the longitudinal association between probable insomnia status and both subjective and objective memory decline in middle-aged and older adults. 26 363 participants, ≥45 years, completed baseline and follow-up (3 years after baseline) self-reported evaluations of sleep and memory, and neuropsychological testing in the following cognitive domains: memory, executive functions, and psychomotor speed. Participants were categorized as having probable insomnia disorder (PID), insomnia symptoms only (ISO), or no insomnia symptoms (NIS), based on sleep questionnaires. Participants were further grouped based on their sleep change over time. Prospective odds of self-reported memory worsening were assessed using logistic regression, and associations between insomnia and cognitive performance were assessed via linear mixed-effects modeling, adjusted for demographic, lifestyle, and medical factors. An increased odds (OR 1.70; 95% CI 1.29-2.26) of self-reported memory worsening was observed for NIS participants at baseline who developed PID at follow-up compared to those who developed ISO or remained NIS. Additionally, participants whose sleep worsened from baseline to follow-up (i.e. transitioned from NIS to ISO, ISO to PID, or NIS to PID) displayed increased odds (OR 1.22; 95% CI 1.10-1.34) of subjective memory worsening at follow-up compared to those who remained insomnia-free or improved their sleep. There were no significant associations between the development of PID or worsening sleep and performance on neuropsychological tests. These findings of an increased odds for subjective memory decline in middle-aged and older adults with insomnia disorder suggest insomnia may be an important target for early interventions addressing age-related cognitive decline.

Identifiants

pubmed: 35877203
pii: 6649765
doi: 10.1093/sleep/zsac176
pmc: PMC9644124
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : FDN154291
Pays : Canada
Organisme : CIHR
ID : MOP 142191
Pays : Canada
Organisme : CIHR
ID : LSA 94473
Pays : Canada
Organisme : CIHR
ID : PJT 153115
Pays : Canada
Organisme : CIHR
ID : PJT 156125
Pays : Canada
Organisme : CIHR
ID : PJT 166167
Pays : Canada
Organisme : CIHR
ID : PJT-153259
Pays : Canada

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Behav Sleep Med. 2007;5(4):279-96
pubmed: 17937583
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
J Sleep Res. 2008 Sep;17(3):335-43
pubmed: 18844819
Behav Sleep Med. 2008;6(1):32-54
pubmed: 18412036
Geriatr Gerontol Int. 2013 Jan;13(1):139-45
pubmed: 22672286
Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):41-8
pubmed: 16493235
Sleep Med. 2006 Mar;7(2):123-30
pubmed: 16459140
JAMA Netw Open. 2021 Feb 1;4(2):e210169
pubmed: 33630089
Sleep. 2012 Apr 01;35(4):491-9
pubmed: 22467987
Cureus. 2019 Oct 26;11(10):e6004
pubmed: 31807391
J Clin Sleep Med. 2018 Jun 15;14(6):1017-1024
pubmed: 29852897
Int J Epidemiol. 2019 Dec 1;48(6):1752-1753j
pubmed: 31633757
JAMA Netw Open. 2020 Sep 1;3(9):e2013573
pubmed: 32955572
Dement Neuropsychol. 2016 Jul-Sep;10(3):170-177
pubmed: 29213452
Clin Neuropsychol. 2017 Jan;31(1):233-250
pubmed: 27830627
Sleep Med. 2009 Oct;10(9):952-60
pubmed: 19748312
BMC Psychiatry. 2011 Jul 01;11:108
pubmed: 21722382
Biomol Ther (Seoul). 2020 Jan 1;28(1):58-73
pubmed: 31838834
Sleep. 2019 Aug 1;42(8):
pubmed: 31089710
BMJ. 2001 Nov 3;323(7320):1058-60
pubmed: 11691768
J Am Geriatr Soc. 2001 Dec;49(12):1628-32
pubmed: 11843995
Nat Commun. 2021 Apr 20;12(1):2289
pubmed: 33879784
Front Aging Neurosci. 2018 Jun 04;10:166
pubmed: 29915534
Acta Psychiatr Scand. 2014 Dec;130(6):439-51
pubmed: 25219393
BMJ. 2010 Mar 19;340:c1425
pubmed: 20304935
J Am Geriatr Soc. 2012 Jun;60(6):1128-34
pubmed: 22690986
Can J Aging. 2009 Sep;28(3):221-9
pubmed: 19860977
Clin Psychol Rev. 2016 Nov;49:106-118
pubmed: 27664823
Sleep Med Rev. 2012 Feb;16(1):83-94
pubmed: 21636297
JAMA Netw Open. 2020 Nov 2;3(11):e2018782
pubmed: 33156345
Physiol Behav. 1999 May;66(3):485-92
pubmed: 10357438
Sleep. 2010 Apr;33(4):459-65
pubmed: 20394314
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Dement Geriatr Cogn Disord. 2006;22(5-6):471-85
pubmed: 17047326
Neurology. 2016 Nov 1;87(18):1916-1924
pubmed: 27708128
J Am Geriatr Soc. 2011 Mar;59(3):559-62
pubmed: 21391952
Alzheimers Dement. 2015 Jun;11(6):718-26
pubmed: 26045020
Lancet Neurol. 2014 Aug;13(8):788-94
pubmed: 25030513
Sleep. 2007 Sep;30(9):1205-11
pubmed: 17910392
Dialogues Clin Neurosci. 2013 Dec;15(4):445-54
pubmed: 24459411
Sleep. 2011 May 01;34(5):565-73
pubmed: 21532949
Semin Hear. 2015 Aug;36(3):111-21
pubmed: 27516712
Neuropsychol Rev. 2008 Mar;18(1):73-90
pubmed: 18347989
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Sleep. 2009 Mar;32(3):295-301
pubmed: 19294949
Arch Gen Psychiatry. 2010 Apr;67(4):414-22
pubmed: 20368517

Auteurs

Jean-Louis Zhao (JL)

Institut Universitaire de Gériatrie de Montréal and CRIUGM, CIUSSS du Centre-Sud-de-l'Ile-de-Montréal, Montreal, Canada.
Department of Neuroscience, Université de Montreal, Montreal, Canada.

Nathan Cross (N)

Institut Universitaire de Gériatrie de Montréal and CRIUGM, CIUSSS du Centre-Sud-de-l'Ile-de-Montréal, Montreal, Canada.
PERFORM Centre, Concordia University, Montreal, Canada.
Department of Health, Kinesiology and Applied Physiology, Center for Studies in Behavioral Neurobiology, Concordia University, Montreal, Canada.
Canadian Sleep and Circadian Network, Montreal, Canada.

Chun W Yao (CW)

Canadian Sleep and Circadian Network, Montreal, Canada.
Integrated Program in Neuroscience, McGill University, Montreal, Canada.
Research Institute of McGill University Health Center, Montreal, Canada.

Julie Carrier (J)

Institut Universitaire de Gériatrie de Montréal and CRIUGM, CIUSSS du Centre-Sud-de-l'Ile-de-Montréal, Montreal, Canada.
Canadian Sleep and Circadian Network, Montreal, Canada.
Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de Montreal, CIUSSS du Nord-de-l'Ile-de-Montréal, Montreal, Canada.
Department of Psychology, Université de Montréal, Montreal, Canada.

Ronald B Postuma (RB)

Canadian Sleep and Circadian Network, Montreal, Canada.
Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de Montreal, CIUSSS du Nord-de-l'Ile-de-Montréal, Montreal, Canada.
Department of Neurology and Neurosurgery, McGill University-Montreal General Hospital, Montreal, Canada.

Nadia Gosselin (N)

Canadian Sleep and Circadian Network, Montreal, Canada.
Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de Montreal, CIUSSS du Nord-de-l'Ile-de-Montréal, Montreal, Canada.
Department of Psychology, Université de Montréal, Montreal, Canada.

Lisa Kakinami (L)

PERFORM Centre, Concordia University, Montreal, Canada.
Department of Mathematics and Statistics, Concordia University, Montreal, Canada.

Thien Thanh Dang-Vu (TT)

Institut Universitaire de Gériatrie de Montréal and CRIUGM, CIUSSS du Centre-Sud-de-l'Ile-de-Montréal, Montreal, Canada.
Department of Neuroscience, Université de Montreal, Montreal, Canada.
PERFORM Centre, Concordia University, Montreal, Canada.
Department of Health, Kinesiology and Applied Physiology, Center for Studies in Behavioral Neurobiology, Concordia University, Montreal, Canada.
Canadian Sleep and Circadian Network, Montreal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH